Eevia Health Plc Logo

Eevia Health Plc

EEVIA | SPGR

Overview

Corporate Details

ISIN(s):
FI4000496658
LEI:
743700NO7D0UA8J1MQ31
Country:
Finland
Address:
Koulukatu 14, FI-60100 SEINÄJOKI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eevia Health Plc is a life science company specializing in the development and manufacturing of scientifically validated bioactive plant extracts. The company produces high-purity, standardized polyphenol ingredients derived from wild-harvested and organically farmed Nordic plant materials. Its product portfolio includes high-strength, excipient-free extracts and condition-specific bioactives designed for the dietary supplement, food, and cosmetics industries. Eevia Health operates on a B2B model, supplying manufacturers globally. Key differentiators include its commitment to sustainability through "Nordic Green Chemistry," a proprietary green-extraction process, and a "Dose Matters™" philosophy that emphasizes proven efficacy. The company's research focuses on health areas such as gut microbiome balance, cognitive function, and metabolic health.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Eevia Health Plc. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Eevia Health Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Eevia Health Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-12 Stein Ulve Other Other 2,726,717 54,534.34 EUR

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Global pharmaceutical company creating innovative treatments for brain diseases.
Denmark HLUN
Hong Kong N/A
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL
Idorsia Ltd Logo
Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.
Switzerland IDIA
Immuno-Biological Laboratories Co., Ltd. Logo Japan 4570
Indivior PLC Logo
A global pharmaceutical firm developing treatments for addiction and mental illness.
United Kingdom INDV
Infant Bacterial Therapeutics Logo
Developing microbiome therapies for premature infants to prevent life-threatening intestinal disease.
Sweden IBT
Intercure Ltd. Logo
Producer of pharma-grade, GMP-certified medical cannabis products for patients outside North America.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines for animal health, led by its vaccine for equine strangles.
Sweden IVACC
Ipsen Logo
Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN